Your trusted source for investing success

Tag: roche

Weyland Tech Updates Investors on Uplisting Status

Weyland Tech (OTCQB:WEYL) has provided an update to shareholders on the status of its NASDAQ application and other key issues regarding market rumors.

As quoted in the press release:
As indicated in previous filings with the Securities and Exchange commission, the Company has filed its NASDAQ application and the standard review by

Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2017

DUBLIN, Ireland, Feb. 10, 2017 (GLOBE NEWSWIRE) — Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three and six month periods ended December 31, 2016.
Recent highlights:Initiated pivotal field efficacy and safety studies of frunevetmab, the Company’s anti-nerve growth factor monoclonal antibody (anti-NGF mAb) in development for the control

Xenon Pharmaceuticals Outlines Key Milestones for 2017

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today outlined its anticipated key corporate milestones for 2017.
Dr. Simon Pimstone, Xenon’s President and Chief Executive Officer, said, “As we enter 2017, these upcoming quarters represent the most data-rich period in our history. We are looking forward to a number of important inflection

Roche Launches cobas® c 513 analyzer and HbA1c Gen. 3 assay

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its new dedicated, high-throughput HbA1c testing solution, the cobas c 513 analyzer, and HbA1c Gen. 3 assay has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

“As diabetes continues to approach epidemic proportions in the U.S. with an estimated 1.4

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network